6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide

C113H129Cl2N33O12 — CID 161051158

IUPAC6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide
SMILESClc1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.Clc1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nn1.O=C(NC1CCC(Oc2cc(N3CCOCC3)cc3nccnc23)CC1)c1cccc(-n2cnnc2)n1.O=C(NC1CCC(Oc2cc(N3CCOCC3)cc3nccnc23)CC1)c1ncn[nH]1.c1cnc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1
InChIInChI=1S/C26H28N8O3.2C22H25ClN6O2.C22H26N6O2.C21H25N7O3/c35-26(21-2-1-3-24(32-21)34-16-29-30-17-34)31-18-4-6-20(7-5-18)37-23-15-19(33-10-12-36-13-11-33)14-22-25(23)28-9-8-27-22;23-20-13-21(27-14-26-20)28-15-1-3-17(4-2-15)31-19-12-16(29-7-9-30-10-8-29)11-18-22(19)25-6-5-24-18;23-20-5-6-21(28-27-20)26-15-1-3-17(4-2-15)31-19-14-16(29-9-11-30-12-10-29)13-18-22(19)25-8-7-24-18;1-6-25-22(26-7-1)27-16-2-4-18(5-3-16)30-20-15-17(28-10-12-29-13-11-28)14-19-21(20)24-9-8-23-19;29-21(20-24-13-25-27-20)26-14-1-3-16(4-2-14)31-18-12-15(28-7-9-30-10-8-28)11-17-19(18)23-6-5-22-17/h1-3,8-9,14-18,20H,4-7,10-13H2,(H,31,35);5-6,11-15,17H,1-4,7-10H2,(H,26,27,28);5-8,13-15,17H,1-4,9-12H2,(H,26,28);1,6-9,14-16,18H,2-5,10-13H2,(H,25,26,27);5-6,11-14,16H,1-4,7-10H2,(H,26,29)(H,24,25,27)
InChIKeyUCDRJOWTIFQILL-UHFFFAOYSA-N
MW2212.40 g/mol
LogP14.75
Rot. Bonds26

About 6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide

6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide (PubChem CID 161051158) has the molecular formula C113H129Cl2N33O12 and a molecular weight of 2212.40 g/mol. Its IUPAC name is 6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide.

Molecular Properties

Compound Name6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide
PubChem CID161051158
Molecular FormulaC113H129Cl2N33O12
Molecular Weight2212.40 g/mol
Exact Mass2209.99
IUPAC Name6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide
SMILESClc1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.Clc1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nn1.O=C(NC1CCC(Oc2cc(N3CCOCC3)cc3nccnc23)CC1)c1cccc(-n2cnnc2)n1.O=C(NC1CCC(Oc2cc(N3CCOCC3)cc3nccnc23)CC1)c1ncn[nH]1.c1cnc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1
InChIInChI=1S/C26H28N8O3.2C22H25ClN6O2.C22H26N6O2.C21H25N7O3/c35-26(21-2-1-3-24(32-21)34-16-29-30-17-34)31-18-4-6-20(7-5-18)37-23-15-19(33-10-12-36-13-11-33)14-22-25(23)28-9-8-27-22;23-20-13-21(27-14-26-20)28-15-1-3-17(4-2-15)31-19-12-16(29-7-9-30-10-8-29)11-18-22(19)25-6-5-24-18;23-20-5-6-21(28-27-20)26-15-1-3-17(4-2-15)31-19-14-16(29-9-11-30-12-10-29)13-18-22(19)25-8-7-24-18;1-6-25-22(26-7-1)27-16-2-4-18(5-3-16)30-20-15-17(28-10-12-29-13-11-28)14-19-21(20)24-9-8-23-19;29-21(20-24-13-25-27-20)26-14-1-3-16(4-2-14)31-18-12-15(28-7-9-30-10-8-28)11-17-19(18)23-6-5-22-17/h1-3,8-9,14-18,20H,4-7,10-13H2,(H,31,35);5-6,11-15,17H,1-4,7-10H2,(H,26,27,28);5-8,13-15,17H,1-4,9-12H2,(H,26,28);1,6-9,14-16,18H,2-5,10-13H2,(H,25,26,27);5-6,11-14,16H,1-4,7-10H2,(H,26,29)(H,24,25,27)
InChIKeyUCDRJOWTIFQILL-UHFFFAOYSA-N
XLogP14.75
TPSA494.20 Ų
H-Bond Donors6
H-Bond Acceptors42
Rotatable Bonds26
Heavy Atoms160
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002212.40
LogP ≤ 514.75
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1042

Analyze 6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide?
The IUPAC name of 6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide (CID 161051158) is 6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide.
What is the SMILES notation for 6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide?
The canonical SMILES for 6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide is Clc1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.Clc1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nn1.O=C(NC1CCC(Oc2cc(N3CCOCC3)cc3nccnc23)CC1)c1cccc(-n2cnnc2)n1.O=C(NC1CCC(Oc2cc(N3CCOCC3)cc3nccnc23)CC1)c1ncn[nH]1.c1cnc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1.
What is the InChIKey of 6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide?
The InChIKey is UCDRJOWTIFQILL-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H28N8O3.2C22H25ClN6O2.C22H26N6O2.C21H25N7O3/c35-26(21-2-1-3-24(32-21)34-16-29-30-17-34)31-18-4-6-20(7-5-18)37-23-15-19(33-10-12-36-13-11-33)14-22-25(23)28-9-8-27-22;23-20-13-21(27-14-26-20)28-15-1-3-17(4-2-15)31-19-12-16(29-7-9-30-10-8-29)11-18-22(19)25-6-5-24-18;23-20-5-6-21(28-27-20)26-15-1-3-17(4-2-15)31-19-14-16(29-9-11-30-12-10-29)13-18-22(19)25-8-7-24-18;1-6-25-22(26-7-1)27-16-2-4-18(5-3-16)30-20-15-17(28-10-12-29-13-11-28)14-19-21(20)24-9-8-23-19;29-21(20-24-13-25-27-20)26-14-1-3-16(4-2-14)31-18-12-15(28-7-9-30-10-8-28)11-17-19(18)23-6-5-22-17/h1-3,8-9,14-18,20H,4-7,10-13H2,(H,31,35);5-6,11-15,17H,1-4,7-10H2,(H,26,27,28);5-8,13-15,17H,1-4,9-12H2,(H,26,28);1,6-9,14-16,18H,2-5,10-13H2,(H,25,26,27);5-6,11-14,16H,1-4,7-10H2,(H,26,29)(H,24,25,27).
What are the key properties of 6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide?
6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide has a molecular weight of 2212.40 g/mol, XLogP of 14.75, 26 rotatable bonds, 6 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for 6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;6-chloro-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-1,2,4-triazole-5-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(1,2,4-triazol-4-yl)pyridine-2-carboxamide is sourced from PubChem (CID 161051158), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).